Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients.
Huntjens DW, Dijkstra JA, Verwiel LN, Slijkhuis M, Elbers P, Welkers MRA, Veldkamp AI, Kuijvenhoven MA, de Leeuw DC, Abdullah-Koolmees H, Kuipers MT, Bartelink IH. Huntjens DW, et al. Among authors: bartelink ih. Pharmaceutics. 2023 Jan 3;15(1):163. doi: 10.3390/pharmaceutics15010163. Pharmaceutics. 2023. PMID: 36678792 Free PMC article. Review.
Pharmacological Optimization of PSMA-Based Radioligand Therapy.
van der Gaag S, Bartelink IH, Vis AN, Burchell GL, Oprea-Lager DE, Hendrikse H. van der Gaag S, et al. Among authors: bartelink ih. Biomedicines. 2022 Nov 23;10(12):3020. doi: 10.3390/biomedicines10123020. Biomedicines. 2022. PMID: 36551776 Free PMC article. Review.
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19.
Baalbaki N, Duijvelaar E, Said MM, Schippers J, Bet PM, Twisk J, Fritchley S, Longo C, Mahmoud K, Maitland-van der Zee AH, Bogaard HJ, Swart EL, Aman J, Bartelink IH. Baalbaki N, et al. Among authors: bartelink ih. Eur J Pharm Sci. 2023 May 1;184:106418. doi: 10.1016/j.ejps.2023.106418. Epub 2023 Mar 2. Eur J Pharm Sci. 2023. PMID: 36870577 Free PMC article. Clinical Trial.
Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients.
van de Stadt EA, Yaqub M, Schuit RC, Bartelink IH, Leeuwerik AF, Schwarte LA, de Langen AJ, Hendrikse H, Bahce I. van de Stadt EA, et al. Among authors: bartelink ih. Diagnostics (Basel). 2022 Apr 1;12(4):883. doi: 10.3390/diagnostics12040883. Diagnostics (Basel). 2022. PMID: 35453931 Free PMC article.
50 results